Intraocular Drug Delivery (Record no. 15740)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00994nam a2200193Ia 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 140223b2006 xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780824728601 |
Terms of availability | 0.00 |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.6 |
Item number | INT |
245 ## - TITLE STATEMENT | |
Title | Intraocular Drug Delivery |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | New York |
Name of publisher, distributor, etc | Taylor & Francis |
Date of publication, distribution, etc | 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 362p |
500 ## - GENERAL NOTE | |
General note | This reference studies the most recent advances in the development of ocular drug delivery systems. Covering methods to treat or prevent ocular inflammation, retinal vascular disease, retinal degeneration, and proliferative eye disease, this source covers breakthroughs in the management of endophthalmitis, uveitis, diabetic macular edema, and age-related macular degeneration. |
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
Personal name | Drug Delivery |
9 (RLIN) | 105131 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jaffe, Glenn J. |
Relator term | Editor |
9 (RLIN) | 105132 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pearson, P. Andrew |
Relator term | Editor |
9 (RLIN) | 105133 |
700 ## - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ashton, Paul |
9 (RLIN) | 105134 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Dewey Decimal Classification |
Item type | Book |
995 ## - RECOMMENDATION 995 [LOCAL, UNIMARC FRANCE] | |
Origin of item (home branch) (free text) | Pharmacy Reference |
Genre | P0002453 |
Section | 615.6 |
Recipient parent organisation code | P0002453 |
No items available.